Furthermore, during late-stage lung cancer, a fraction of patients exhibited a decrease in Nm23-H1 expression, whereas the remaining patients showed increases in Nm23-H1 expression; in addition, a poor prognosis was observed for patients with decreased Nm23-H1 levels. This evidence concerns the gene NME1 and lung carcinoma.